{"disease":{"id":"unresectable-chordoma","name":"unresectable chordoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05041127","title":"Cetuximab for the Treatment of Advanced Unresectable or Metastatic Chordoma","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":29,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT03623854","title":"Nivolumab and Relatlimab in Treating Participants With Advanced Chordoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Jonsson Comprehensive Cancer Center","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}